Longtime friend and ARVO President Dan Stamer, PhD, tells us about his EyeFind initiative, alternative plans for this year’s annual meeting, how research is a team sport, and why he and other scientists are desperate to get back to the lab.
University of Denver Alzheimer’s researcher Lotta Granholm-Bentley, PhD, DDS, is playing a key role in her community’s medical response to the coronavirus, and working with Colorado seniors to help combat the sense of isolation many are feeling during these difficult times.
As the global coronavirus pandemic began to hit our nation, University of Kentucky Alzheimer’s researcher Donna M. Wilcock, PhD and her team wanted to do something to help their community address the shortage of medical supplies hindering the local response.
Gains in life expectancy have been accompanied by a rise in age-related diseases, including Alzheimer’s disease, macular degeneration, and glaucoma. Geroscience, as a field, wants to reduce age-related diseases, and BrightFocus is excited about partnering with this interdisciplinary field. .
Geroscience, as a field, seeks to intervene with aspects of aging that increase the risk of disease. In a Q&A, BrightFocus VP of Scientific Affairs Diane Bovenkamp, PhD, thinks that could help find cures for diseases of mind and sight.
The BrightFocus Glaucoma Fast Track Workshop is a day-long workshop providing a unique immersive environment for early-stage scientists focused on glaucoma research or those who want to enter the field to accelerate their path towards becoming an expert in this exciting field.
BrightFocus is once again leading Alzheimer’s Fast Track, a several day incubator for some of the world’s most promising early career researchers. By encouraging and supporting these women and men, BrightFocus hopes to accelerate the path to a cure for the disease.